2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress

October 24 - 25, 2019 | Boston, USA
CONFERENCE SPEAKERS
Advisors
Charles Makin
Charles Makin
Global Head, Real World Evidence Strategy ,
Biogen, Cambridge



Paul Petraro
Paul Petraro
Director Pharmacoepidemiology ,
Regeneron Pharmaceuticals New York



Brian Sweet
Brian Sweet
Executive Director, Oncology, Real World Evidence ,
Bristol-Myers Squibb,New York



Speakers
Vic Spain
Vic Spain
Senior Real World Data Scientist ,
Genentech, San Francisco



Hannah Ebben
Hannah Ebben
Marketing Analytics Specialist,
Takeda Pharmaceuticals


 Hannah Ebben is the Marketing Analytics Specialist at Takeda, where she focuses on generating strategic insights from real-world data and leveraging her background in statistics and coding to produce robust analyses.

Hannah received a Masters in Biochemistry from the University of Colorado and worked in a computational chemistry research lab before realizing bench science was not the career path for her. She spent a year overseas teaching science courses at a university in Rwanda before beginning an MBA program at Northeastern University. While in Boston, Hannah worked at Biogen in a global insights function, gaining experience in market research, forecasting, and data analytics for a launching brand.


Rachel Twardowski
Rachel Twardowski
Associate Director, Specialty Analytics,
Takeda Pharmaceuticals



David Miller
David Miller
Senior Director and Global head of Epidemiology,
UCB



Nneka Onwudiwe
Nneka Onwudiwe
PRO/PE Regulatory Review Officer ,
FDA



Senior Representative
Senior Representative
,
Syneos Health



Senior Representative
Senior Representative
Decision Resources Group,



Sofia Iqbal Kring
Sofia Iqbal Kring
Real World Evidence and Core Clinical Trials Manager,
Novo Nordisk



Gregory Daniel
Gregory Daniel
Deputy Center Director, Duke-Margolis Center for Health Policy,
Duke University



Marla Curran
Marla Curran
Executive Director, Head of Biometrics & Medical Writing,
Paratek Pharmaceuticals



 Valerie (Hastings) Strezsak
Valerie (Hastings) Strezsak
Epidemiologist,
Takeda Pharmaceuticals



Shailendra Singh (Shelly)
Shailendra Singh (Shelly)
Chief Operating Officer,
MarketsandMarkets


Shailendra Singh (Shelly) is Chief Operating Officer of MnM and a member of its board. He focuses on global sales and client services functions, as well as commercial optimization at MarketsandMarkets. He has years of expe¬rience in global delivery and outsourcing sector in the IT/ Consulting/Analytics/Big Data sectors. Prior to MnM, he was leading the global sales, client services and commercial ef¬fectiveness functions for Mu Sigma, a unicorn company and a leading global provider of Decision Sciences and Big Data analytics solutions.


Swetha Rao Palli
Swetha Rao Palli
Associate Director ,
Boehringer Ingelheim, New York



Jyotsna Kasturi
Jyotsna Kasturi
Associate Director, Real World Evidence Statistics,
Teva Pharmaceuticals, New York



Susan Fish
Susan Fish
Associate Director, Registries and Real-World Data,
Celgene, San Francisco



Jennifer L. Wong
Jennifer L. Wong
Senior Director, Real World Evidence Strategy & Al,
AstraZeneca, Gaithersburg



Alex Mutebi
Alex Mutebi
Director, Global Real World Evidence,
Vertex Pharmaceuticals, Boston



Robert Zambon
Robert Zambon
Real World Evidence and Research Innovation and Te,
The Janssen Pharmaceutical Companies of Johnson &



CJ Farhan Hameed
CJ Farhan Hameed
Senior Director, Global Real World Evidence Center,
Pfizer,New York



Brian Sweet
Brian Sweet
Executive Director, Oncology, Real World Evidence ,
Bristol-Myers Squibb,New York



Charles Makin
Charles Makin
Global Head, Real World Evidence Strategy ,
Biogen, Cambridge